There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
The Ebola outbreak caused by the Bundibugyo strain in the Democratic Republic of Congo and Uganda has killed over 500 people and sickened more than 1,560. The World Health Organization has begun clinical trials testing the antiviral remdesivir and the monoclonal antibody MBP-134, both existing drugs being repurposed for this strain. The trials involve collaboration among WHO, Africa CDC, universities, nonprofits, and U.S. BARDA funding, with initial enrollment at a single clinic in the DRC and plans to expand.
- ▪The outbreak, declared over 50 days ago, has resulted in more than 500 deaths and 1,560 infections.
- ▪The first patients have been enrolled in a WHO‑coordinated trial testing remdesivir and MBP-134 against the Bundibugyo Ebola strain.
- ▪BARDA, a U.S. government agency, funded and supplied the MBP-134 doses for the trial.
- ▪The trial will assess each drug alone and in combination, compared with standard supportive care.
- ▪Only one clinic in the DRC is currently participating, with expansion expected in the coming weeks.
NPR — News files mainly under news. We currently carry 535 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | NPR Topics: News |
| Canonical URL | https://www.npr.org/2026/07/07/g-s1-132218/theres-no-treatment-designed-for-the-ebola-strain-ravaging-drc-but-now-theres-hope |
| Publication time | Tue, 07 Jul 2026 08:51:59 -0400 |
| Retrieval time | 2026-07-07T13:05:57.372Z |
| Last seen | 2026-07-07T13:05:57.372Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | xmeMZSJUB8Pg |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Global Health There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope July 7, 20268:51 AM ET By Jonathan Lambert A health worker takes a woman's temperature as part of Ebola screening efforts in Goma, Democratic Republic of Congo. As part of the effort to quash the outbreak, the first patients have been enrolled in a clinical trial to test two drugs against the Bundibugyo strain of the virus that is spreading there. In addition, researchers plan to study whether another drug could protect people exposed to the virus. Daniel Buuma/Getty Images hide caption toggle caption Daniel Buuma/Getty Images It's been over 50 days since the Ebola outbreak was declared in the Democratic Republic of Congo and Uganda.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at NPR Topics: News.
Discussion
0 commentsMore from NPR Topics: News
